Viroclinics Biosciences

Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer

Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer.

OTE0004
20.07.2020 17:12